DEA Required MATE Training

Required MATE Act Training (Treatment and Management of Patients with Opioid or Other Substance Use Disorders).

Have you received a letter from the DEA stating you need to complete 8 hours of training on the treatment and management of patients with opioid or other substance use disorders?  The deadline for satisfying this new training requirement is the date of your next scheduled DEA registration submission on or after June 27, 2023. Here's a document with some options listed and below is also a list of places ACMS is aware of where you can pick up this training. 

 About the New Law

The Mainstreaming Addiction Treatment (MAT) Act updates federal rules to address the public health crisis driven by the opioid epidemic and empowers all health care providers with a standard controlled medication license to prescribe buprenorphine for opioid use disorder, just as they prescribe other essential medications.

The Medication Access and Training Expansion (MATE) Act standardizes substance use disorder training to ensure that all prescribers of addictive medications possess baseline knowledge in evidence-based addiction prevention and treatments.

1) The new training requirement under the MATE Act is only for prescribers with a DEA license that allows them to prescribe controlled substances under schedules II, III, IV, or V.

2) This new requirement begins June 21, 2023. This will be for all new applications and first renewal cycle after this date.

It is a one-time Substance Use Disorder (SUD) education requirement for DEA prescribers. Under Section 1263 of the CAA 2023, the one-time SUD education requirement becomes a condition on a controlled medication prescriber's DEA registration beginning with the first applicable registration. The "first applicable registration" is defined as the first DEA registration or renewal of the DEA registration by a controlled medication prescriber that occurs on or after the date that is 180 days after the law’s enactment.

3) This does not affect any license renewals between now and June 21, 2023.

4) Additionally, the MAT Act has eliminated the X-Waiver program. This was effective immediately in December 2022.

5) There is no new training requirement for prescribers who do not have a DEA number.

For more information.